Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review.
internet
medical marijuana
medicinal cannabis
public health surveillance
social media
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
27 02 2023
27 02 2023
Historique:
received:
20
01
2022
accepted:
16
12
2022
revised:
31
08
2022
entrez:
27
2
2023
pubmed:
28
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
The use and acceptance of medicinal cannabis is on the rise across the globe. To support the interests of public health, evidence relating to its use, effects, and safety is required to match this community demand. Web-based user-generated data are often used by researchers and public health organizations for the investigation of consumer perceptions, market forces, population behaviors, and for pharmacoepidemiology. In this review, we aimed to summarize the findings of studies that have used user-generated text as a data source to study medicinal cannabis or the use of cannabis as medicine. Our objectives were to categorize the insights provided by social media research on cannabis as medicine and describe the role of social media for consumers using medicinal cannabis. The inclusion criteria for this review were primary research studies and reviews that reported on the analysis of web-based user-generated content on cannabis as medicine. The MEDLINE, Scopus, Web of Science, and Embase databases were searched from January 1974 to April 2022. We examined 42 studies published in English and found that consumers value their ability to exchange experiences on the web and tend to rely on web-based information sources. Cannabis discussions have portrayed the substance as a safe and natural medicine to help with many health conditions including cancer, sleep disorders, chronic pain, opioid use disorders, headaches, asthma, bowel disease, anxiety, depression, and posttraumatic stress disorder. These discussions provide a rich resource for researchers to investigate medicinal cannabis-related consumer sentiment and experiences, including the opportunity to monitor cannabis effects and adverse events, given the anecdotal and often biased nature of the information is properly accounted for. The extensive web-based presence of the cannabis industry coupled with the conversational nature of social media discourse results in rich but potentially biased information that is often not well-supported by scientific evidence. This review summarizes what social media is saying about the medicinal use of cannabis and discusses the challenges faced by health governance agencies and professionals to make use of web-based resources to both learn from medicinal cannabis users and provide factual, timely, and reliable evidence-based health information to consumers.
Sections du résumé
BACKGROUND
The use and acceptance of medicinal cannabis is on the rise across the globe. To support the interests of public health, evidence relating to its use, effects, and safety is required to match this community demand. Web-based user-generated data are often used by researchers and public health organizations for the investigation of consumer perceptions, market forces, population behaviors, and for pharmacoepidemiology.
OBJECTIVE
In this review, we aimed to summarize the findings of studies that have used user-generated text as a data source to study medicinal cannabis or the use of cannabis as medicine. Our objectives were to categorize the insights provided by social media research on cannabis as medicine and describe the role of social media for consumers using medicinal cannabis.
METHODS
The inclusion criteria for this review were primary research studies and reviews that reported on the analysis of web-based user-generated content on cannabis as medicine. The MEDLINE, Scopus, Web of Science, and Embase databases were searched from January 1974 to April 2022.
RESULTS
We examined 42 studies published in English and found that consumers value their ability to exchange experiences on the web and tend to rely on web-based information sources. Cannabis discussions have portrayed the substance as a safe and natural medicine to help with many health conditions including cancer, sleep disorders, chronic pain, opioid use disorders, headaches, asthma, bowel disease, anxiety, depression, and posttraumatic stress disorder. These discussions provide a rich resource for researchers to investigate medicinal cannabis-related consumer sentiment and experiences, including the opportunity to monitor cannabis effects and adverse events, given the anecdotal and often biased nature of the information is properly accounted for.
CONCLUSIONS
The extensive web-based presence of the cannabis industry coupled with the conversational nature of social media discourse results in rich but potentially biased information that is often not well-supported by scientific evidence. This review summarizes what social media is saying about the medicinal use of cannabis and discusses the challenges faced by health governance agencies and professionals to make use of web-based resources to both learn from medicinal cannabis users and provide factual, timely, and reliable evidence-based health information to consumers.
Identifiants
pubmed: 36848191
pii: v25i1e36667
doi: 10.2196/36667
pmc: PMC10012004
doi:
Substances chimiques
Medical Marijuana
0
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e36667Informations de copyright
©Sedigh Khademi, Christine Mary Hallinan, Mike Conway, Yvonne Bonomo. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.02.2023.
Références
J Cannabis Res. 2022 Jul 11;4(1):37
pubmed: 35820952
Cyberpsychol Behav Soc Netw. 2015 Jun;18(6):311-9
pubmed: 26075917
Cannabis Cannabinoid Res. 2016 Dec 01;1(1):244-251
pubmed: 28861496
Harm Reduct J. 2017 Sep 5;14(1):60
pubmed: 28870224
Am J Public Health. 2020 Oct;110(S3):S294-S299
pubmed: 33001729
Cannabis Cannabinoid Res. 2020 Dec 15;5(4):337-339
pubmed: 33381647
Drug Alcohol Depend. 2015 Oct 1;155:307-11
pubmed: 26338481
PLoS One. 2022 Feb 8;17(2):e0263583
pubmed: 35134074
Medicines (Basel). 2018 Dec 23;6(1):
pubmed: 30583596
Drug Alcohol Depend. 2015 Oct 1;155:45-51
pubmed: 26347408
Cannabis Cannabinoid Res. 2022 Apr;7(2):207-213
pubmed: 33998849
Prev Sci. 2018 Feb;19(2):127-137
pubmed: 28681195
Nicotine Tob Res. 2017 Aug 01;19(8):952-959
pubmed: 28340059
Cureus. 2019 Jan 19;11(1):e3918
pubmed: 30931189
Drug Alcohol Depend. 2016 Sep 01;166:100-8
pubmed: 27402550
Child Abuse Negl. 2020 May;103:104312
pubmed: 32200194
Subst Use Misuse. 2021;56(7):1074-1077
pubmed: 33821757
J Med Internet Res. 2021 Dec 20;23(12):e27307
pubmed: 34932014
Brain Sci. 2020 May 01;10(5):
pubmed: 32370097
JAMA Netw Open. 2020 Oct 1;3(10):e2020977
pubmed: 33057645
Mo Med. 2020 Mar-Apr;117(2):159-164
pubmed: 32308243
JMIR Public Health Surveill. 2017 Oct 26;3(4):e77
pubmed: 29074469
Drug Alcohol Depend. 2016 Jul 01;164:64-70
pubmed: 27185160
Ther Drug Monit. 2020 Feb;42(1):98-101
pubmed: 31479044
Curr Opin Psychol. 2019 Dec;30:98-102
pubmed: 31071592
Nat Commun. 2018 Nov 20;9(1):4787
pubmed: 30459415
Cerebrum. 2017 Jan 01;2017:
pubmed: 28698772
Int J Drug Policy. 2020 Mar;77:102688
pubmed: 32092666
Aust Prescr. 2020 Oct;43(5):152-159
pubmed: 33093741
Int J Environ Res Public Health. 2022 Aug 10;19(16):
pubmed: 36011488
Subst Use Misuse. 2020;55(13):2213-2220
pubmed: 32715862
Arch Gen Psychiatry. 1972 Feb;26(2):101-8
pubmed: 4551255
Epidemiol Psychiatr Sci. 2016 Apr;25(2):113-22
pubmed: 26744309
PLoS One. 2019 May 6;14(5):e0216556
pubmed: 31059531
JMIR Pediatr Parent. 2020 Dec 7;3(2):e20913
pubmed: 33284128
Subst Abus. 2018;39(2):129-133
pubmed: 28723265
J Med Internet Res. 2019 Aug 15;21(8):e12610
pubmed: 31411142
JAMA. 2017 Nov 7;318(17):1708-1709
pubmed: 29114823
J Psychopharmacol. 2022 Jun;36(6):661-665
pubmed: 34344208
Int J Drug Policy. 2019 Dec;74:11-17
pubmed: 31400582
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2021 Dec;2021:3083-3088
pubmed: 35096472
Front Big Data. 2019 Jul 11;2:13
pubmed: 33693336
JMIR Form Res. 2022 Feb 25;6(2):e35027
pubmed: 35212637
JMIR Public Health Surveill. 2020 Oct 5;6(4):e18540
pubmed: 33016888
BMC Complement Med Ther. 2020 Nov 23;20(1):363
pubmed: 33228697
Cancer. 2020 Jan 1;127(1):67-73
pubmed: 32986266
Allergy Asthma Proc. 2015 Nov-Dec;36(6):e121-6
pubmed: 26534743
J Med Internet Res. 2022 Nov 16;24(11):e35974
pubmed: 36383417
J Health Commun. 2018;23(12):1036-1043
pubmed: 30395785
Drug Alcohol Depend. 2017 May 1;174:192-200
pubmed: 28365173
J Cancer Res Clin Oncol. 2020 Jul;146(7):1857-1865
pubmed: 32219517
PLoS One. 2016 May 26;11(5):e0156614
pubmed: 27227537
Health Commun. 2022 Sep;37(10):1305-1315
pubmed: 33602000
J Med Internet Res. 2020 Oct 30;22(10):e21743
pubmed: 33001829
Ophthalmol Glaucoma. 2021 Jul-Aug;4(4):400-404
pubmed: 33242684
JMIR Public Health Surveill. 2017 Dec 20;3(4):e98
pubmed: 29263018
Reg Anesth Pain Med. 2020 Aug;45(8):597-602
pubmed: 32503862
Patient Educ Couns. 2017 Oct;100(10):1943-1950
pubmed: 28602568
JAMA Netw Open. 2019 Oct 2;2(10):e1913853
pubmed: 31642924
PLoS One. 2023 Jan 20;18(1):e0269143
pubmed: 36662832
BMJ Open. 2021 Oct 22;11(10):e054044
pubmed: 34686558
Addict Behav. 2014 Aug;39(8):1278-85
pubmed: 24821471
Drug Alcohol Depend. 2014 Feb 1;135:88-94
pubmed: 24332802
Am J Hosp Palliat Care. 2017 Feb;34(1):85-91
pubmed: 26377551
J Cannabis Res. 2021 May 6;3(1):13
pubmed: 33957993
Drug Alcohol Depend. 2018 Jul 1;188:364-369
pubmed: 29883950
Am J Public Health. 2020 Mar;110(3):357-362
pubmed: 31855475
Eur J Clin Invest. 2018 Jun;48(6):e12931
pubmed: 29578574
J Adolesc Health. 2015 Feb;56(2):139-45
pubmed: 25620299
Ophthalmic Physiol Opt. 2014 Jan;34(1):46-52
pubmed: 24325434
J Hand Surg Glob Online. 2021 Jan;3(1):36-40
pubmed: 33537664